Back to the main directory
EarningsReview / Equity
- Volvo (Buy, TP: SEK190.00) - Passes the first exam by DnB Markets
- Europris (Buy, TP: NOK36.00) - Outperforming the market by far by DnB Markets
- TietoEVRY (Buy, TP: EUR33.00) - Dust about to settle by DnB Markets
- Stolt-Nielsen (Buy, TP: NOK140.00) - Orderbook 5.6% of the fleet by DnB Markets
- AcadeMedia AB (Buy, TP: SEK77.00) - Solid, but with underlying volatility by DnB Markets
- The weekly navigator by DnB Markets
- PGS (Sell, TP: NOK14.00) - Another year of value destruction by DnB Markets
- Q4 season underway by DnB Markets
- Lundin Petroleum - ESG efforts hampering near-term dividend capacity by Danske Bank Equity Research
- Novartis (NOVN SW) by HSBC
- Why we are positive ahead of tomorrow''s strategic review update by BNP Paribas
- Q4 miss, forest revaluation, but cautious 2020 outlook by BNP Paribas
- 360 Report | Tokmanni Group | Buy | Discounted sweet spot by Kepler Cheuvreux
- Investment Daily 03/02/2020 by BNP Paribas
- (Semaine du 27 au 31 janvier 2019) by Oddo BHF
- 2020 off to a slow start despite market bounce by BNP Paribas
- Year of the Rat - Something for Everyone by BNP Paribas
- Execution issues persist by BNP Paribas
- In The Flow by BNP Paribas
- Solid Q3 FY 20 but soft guidance for Q4 FY 20 by BNP Paribas
- Epiroc (Buy, TP: SEK125.00) - Service and savings set to support by DnB Markets
- Ultimovacs (Buy, TP: NOK66.00) - Moving into mesothelioma by DnB Markets
- Stora Enso (Hold, TP: EUR12.40) - Soft outlook, patience required by DnB Markets
- LeoVegas Minor model adjustments by DnB Markets
- Jm Ab (Sell, TP: SEK230.00) - Solid Q4, but IFRS risk materialising by DnB Markets
- Wärtsilä (Sell, TP: EUR8.50) - Q4 a relief, but risks remain by DnB Markets
- Novo Nordisk (Buy, TP: DKK460.00) - 2020 guidance and Rybelsus key by DnB Markets
- UPM (Hold, TP: EUR30.00) - More challenging H1 2020e by DnB Markets
- Metso (Buy, TP: EUR42.00) - Neles to control the flow by DnB Markets
- Hennes & Mauritz (Sell, TP: SEK170.00) - Struggling growth outlook by DnB Markets
- Handicare (Buy, TP: SEK44.00) - Divestment set to hurt by DnB Markets
- Outotec (Buy, TP: EUR7.00) - Healthier operations by DnB Markets
- Dometic - Poor ending, but end-markets should turn in 2020 by Danske Bank Equity Research
- Electrolux (Sell, TP: SEK215.00) - Needs a spin-off doctor by DnB Markets
- Q4 beat with German Bio-chemical plant approval by BNP Paribas
- Waking sleeping beauty by BNP Paribas
- What goes on Tour by BNP Paribas
- Electrolux - Once the dust has settled the shares are attractive by Danske Bank Equity Research
- Not this year by BNP Paribas
- 27 – 31 January 2020 by Oddo BHF
- The Road to Redemption by BNP Paribas
- LG Chemical Limited (051910 KS) by HSBC
- 4Q19 results and questions for management by BNP Paribas
- Continuing strengths, stabilising margins by BNP Paribas
- Dometic (Buy, TP: SEK107.00) - In transition but weak demand by DnB Markets
- Nordic Semiconductor (Buy, TP: NOK71.00) - Something’s in the works by DnB Markets
- Maersk Drilling (Buy, TP: DKK600.00) - Dividends in sight by DnB Markets
- HMS Networks (Buy, TP: SEK170.00) - Q4 the low-water mark by DnB Markets
- Tanker News Flash (DNB Markets) - Cosco Dalian off US's sanctions list by DnB Markets
- Swedish Orphan Biovitrum (Buy, TP: SEK275.00) - Focus on 2020 guidance by DnB Markets